EC/FDA joint inspections

被引：0
|
作者：
Barbara Nasto
机构：
来源：
Nature Biotechnology | 2008年 / 26卷 / 8期
关键词：
D O I：
10.1038/nbt0808-847b
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：847 / 847
相关论文
共 50 条
  • [41] Why (not) go east? comparison of FDA inspections from cee, we and us investigational site inspections
    Caldron, P. H.
    Gavrilova, S. I.
    Kropf, S.
    EUROPEAN PSYCHIATRY, 2013, 28
  • [42] International: Congress focuses on FDA inspections of foreign drug facilities
    Van, Arnum, Patricia
    Pharmaceutical Technology, 2007, 31 (11)
  • [43] Reflections on the Saudi FDA Regulatory Experience with Smart GxP Inspections
    Alhomaidan, Ali M.
    Al-Murikhi, Nawaf G.
    Al-Qarni, Morae A.
    Al Fahaadi, Fahad A.
    Al Otaibi, Khalid S.
    Hafiz, Radwan
    Almadani, Ohoud A.
    Al Rafie, Turki A.
    Al Ageel, Mohammed A.
    Dahhas, Mohammed A.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (04) : 730 - 745
  • [44] Tighter FDA budget may mean fewer, shorter inspections
    Dickinson, James G.
    Medical Device and Diagnostic Industry, 1998, 20 (03): : 48 - 49
  • [45] Survival guide to FDA inspections - Part 3, responding to observations
    Lavian, M
    Allen, PW
    BIOPHARM INTERNATIONAL-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2002, 15 (11): : 42 - 44
  • [46] Book review: Preparing for FDA pre-approval inspections
    Journal of the American Chemical Society, 2000, 122 (07)
  • [47] FDA Clinical Investigator Site Inspections: The Sponsor’s Role
    Richard D. Huddleston
    Drug information journal : DIJ / Drug Information Association, 1999, 33 (3): : 965 - 968
  • [48] FOOD AND DRUG LAW INSTITUTE - FDA PLANS NEW INSPECTIONS
    不详
    DRUG & COSMETIC INDUSTRY, 1977, 120 (01): : 37 - &
  • [49] FDA clinical investigator site inspections: The sponsor's role
    Huddleston, RD
    DRUG INFORMATION JOURNAL, 1999, 33 (03): : 965 - 968
  • [50] NAPM - KLEINFELD ASSAILS UNREASONABLE INSPECTIONS FDA PRAISES IDIP
    不详
    DRUG & COSMETIC INDUSTRY, 1969, 104 (03): : 78 - &
12345